NMRA

NEUMORA THERAPEUTICS INC.

NMRA·640979100·US·Common Stock·Healthcare - Biotechnology-Activist

NMRA (NEUMORA THERAPEUTICS INC.) is held by 69 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($13.2M), SOFTBANK GROUP CORP. ($10.4M), VANGUARD CAPITAL MANAGEMENT LLC ($7.9M). Net institutional sentiment: Mixed.

69
Holders
(3 Elite)
$78.9M
Total Value
59% (73)
Consensus
43 buying - 30 selling
13F: Insider & Congress: Updated regularly
NMRA

Smart Money Verdict

View all
Loading verdict
Held by 69 funds
3 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 21, 2026 · Activists May 15, 2026 · Congress none

InsiderASAurora Daljit SinghSell $33KAug 21, 2026
InsiderASAurora Daljit SinghExercise 21K shAug 21, 2026
InsiderASAurora Daljit SinghExercise 21K shAug 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.8M(+279.3%)$13.2M0.0%-59.88%
45
Unchanged
6.1M$10.4M0.1%-86.97%
0
Increased
4.7M(+20.0%)$7.9M0.0%-44.94%
33
Increased
3.5M(+0.0%)$5.9M0.0%-85.87%
27
Unchanged
3.3M$5.6M0.1%-88.94%
0
Increased
2.6M(+139.9%)$4.4M0.0%-71.53%
43
Increased
2.2M(+10.2%)$3.8M0.0%-27.81%
29
Increased
1.6M(+296.8%)$2.7M0.0%-60.47%
42
Increased
1.4M(+75.8%)$2.3M0.0%-36.93%
39
Decreased
1.3M(-9.1%)$2.1M0.0%+35.91%
0
Decreased
904,458(-24.3%)$1.5M0.0%-35.80%
0
Increased
894,791(+384.1%)$1.5M0.0%-21.25%
41
Increased
828,933(+141.3%)$1.4M0.0%-9.77%
41
Increased
823,583(+59.5%)$1.4M0.0%-79.83%
37
Increased
800,571(+306.6%)$1.4M0.0%-61.26%
41
New
784,679$1.3M0.0%-8.24%
35
Increased
706,667(+32.1%)$1.2M0.0%-42.85%
32
Increased
577,615(+62.8%)$982,1090.0%-27.83%
36
Decreased
509,210(-81.5%)$865,6570.0%-28.82%
0
Increased
405,324(+48.0%)$689,0510.0%-10.37%
34

Showing 1-20 of 80

1 / 4
NMRANMRANEUMORA THERAPEUTICS INC.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used